Ciprofloxacin Myungmoon is an antibiotic in a group of drugs called fluoroquinolones. Ciprofloxacin Myungmoon fights bacteria in the body. Ciprofloxacin Myungmoon is used to treat different types of bacterial infections. Ciprofloxacin Myungmoon is also used to treat people who have been exposed to anthrax. Ciprofloxacin Myungmoon may also be used for purposes not listed in Ciprofloxacin Myungmoon guide.
How is Ciprofloxacin Myungmoon given?
Follow all directions on your prescription label. Do not use this medicine in larger or smaller amounts or for longer than recommended. Ciprofloxacin Myungmoon is injected into a vein through an IV. You may be shown how to use an IV at home. Do not self-inject this medicine if you do not understand how to give the injection and properly dispose of used needles, IV tubing, and other items used to inject the medicine. Ciprofloxacin Myungmoon must be injected slowly, over at least 60 minutes. Drink plenty of liquids while you are using Ciprofloxacin Myungmoon. Ciprofloxacin Myungmoon is usually given every 8 to 12 hours for up to 14 days. Some infections may need to be treated for 4 to 6 weeks. Anthrax exposure is usually treated for 60 days. Follow your doctor's dosing instructions very carefully. Use this medicine for the full prescribed length of time. Your symptoms may improve before the infection is completely cleared. Skipping doses may also increase your risk of further infection that is resistant to antibiotics. Ciprofloxacin Myungmoon will not treat a viral infection such as the flu or a common cold. If you use this medicine long-term, you may need frequent medical tests at your doctor's office. Store at room temperature away from moisture, heat, and light. Do not freeze. Do not use Ciprofloxacin Myungmoon if it has changed colors or has particles in it. Call your pharmacist for new medication.
Ciprofloxacin Myungmoon side effects
Get emergency medical help if you have any of these signs of an allergic reaction: hives, tingling; fast or slow heartbeats, weak pulse, feeling like you might pass out; difficult breathing; swelling of your face, lips, tongue, or throat. Ciprofloxacin Myungmoon may cause swelling or tearing of (rupture) a tendon. Ciprofloxacin Myungmoon can also have serious effects on your nerves, and may cause permanent nerve damage. Stop using this medicine and call your doctor at once if you have:
signs of tendon rupture--sudden pain, swelling, bruising, tenderness, stiffness, movement problems, or a snapping or popping sound in any of your joints (rest the joint until you receive medical care or instructions); or
nerve symptoms--numbness, tingling, burning pain, or being more sensitive to temperature, light touch, or the sense of your body position.
Also, stop using Ciprofloxacin Myungmoon and call your doctor at once if you have:
muscle weakness or trouble breathing;
headache with chest pain and severe dizziness, fainting, fast or pounding heartbeats;
the first sign of any skin rash, no matter how mild;
diarrhea that is watery or bloody;
confusion, hallucinations, nightmares, paranoia, depression, thoughts about hurting yourself;
pale skin, easy bruising or bleeding (nosebleeds, bleeding gums);
seizure (convulsions);
sudden weakness or ill feeling, fever, chills, swollen glands, sore throat, mouth sores, red or swollen gums, trouble swallowing;
liver problems--nausea, upper stomach pain, itching, tired feeling, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes);
increased pressure inside the skull-- severe headaches, ringing in your ears, dizziness, vision problems, pain behind your eyes;
signs of a kidney problem--little or no urinating, pink or red urine, swelling, rapid weight gain, feeling drowsy or short of breath;
swelling of your blood vessels--fever, loss of appetite, numbness, weakness, tired feeling, weight loss; or
severe skin reaction--fever, sore throat, swelling in your face or tongue, burning in your eyes, skin pain, followed by a red or purple skin rash that spreads (especially in the face or upper body) and causes blistering and peeling.
Common side effects may include:
nausea, vomiting, diarrhea, stomach pain;
dizziness, agitation, feeling anxious or nervous;
tremors, sleep problems (insomnia);
vaginal itching or discharge;
skin rash; or
abnormal liver function tests.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. See also: Side effects (in more detail)
Ciprofloxacin Myungmoon dosing
Usual Adult Dose for Anthrax Prophylaxis:
Prophylaxis postexposure to inhalational Bacillus anthracis: IV: 400 mg IV every 12 hours Oral: 500 mg orally every 12 hours Treatment should start as soon as possible following suspected or confirmed exposure. Total duration of therapy is 60 days.
Usual Adult Dose for Inhalation Bacillus anthracis:
(Not approved by FDA) Centers for Disease Control and Prevention (CDC) recommendations: Treatment of inhalational anthrax associated with bioterrorism attack: 400 mg IV every 12 hours plus 1 or 2 additional antibiotics with activity against the causative organism; these drugs may include rifampin, vancomycin, penicillin, ampicillin, chloramphenicol, imipenem, clindamycin, and clarithromycin Duration: The switch from IV to oral antimicrobial therapy (ciprofloxacin 500 mg orally every 12 hours) may be made as soon as is clinically feasible. Therapy should continue for a total of 60 days (IV and oral combined).
Usual Adult Dose for Cutaneous Bacillus anthracis:
CDC recommendations: Treatment of cutaneous anthrax associated with bioterrorism attack: 500 mg orally every 12 hours for 60 days IV therapy (ciprofloxacin 400 mg IV every 12 hours) with multiple drugs is recommended if there is evidence of systemic involvement, severe edema, or if head or neck lesions are present.
Usual Adult Dose for Bacteremia:
Secondary bacteremia associated with urinary tract infections caused by Escherichia coli: 400 mg IV every 12 hours Therapy should be continued for 7 to 14 days, depending on the nature and severity of the infection.
Usual Adult Dose for Bronchitis:
Acute exacerbations of chronic bronchitis: Mild/moderate: IV: 400 mg IV every 12 hours Oral: 500 mg orally every 12 hours Severe/complicated: IV: 400 mg IV every 8 hours Oral: 750 mg orally every 12 hours Duration: 7 to 14 days
Usual Adult Dose for Chancroid:
CDC recommendations: 500 mg orally twice a day for 3 days The patient's sexual partner(s) should also be evaluated/treated.
Usual Adult Dose for Cholera:
(Not approved by FDA) Infectious Diseases Society of America (IDSA) recommendations: 1 g orally once, as an adjunct to fluid and electrolyte replacement
Usual Adult Dose for Cystitis:
Acute uncomplicated: Immediate-release: 250 mg orally every 12 hours Extended-release: 500 mg orally every 24 hours Duration: 3 days
Usual Adult Dose for Febrile Neutropenia:
Empirical therapy in febrile neutropenic patients: Severe: 400 mg IV every 8 hours for 7 to 14 days, in combination with piperacillin 50 mg/kg IV every 4 hours
Usual Adult Dose for Gonococcal Infection -- Uncomplicated:
Uncomplicated urethral and cervical gonococcal infections: 250 mg orally one time Due to high rates of resistance, the CDC does not recommend fluoroquinolones for treatment of gonococcal infections in the United States. Ceftriaxone or oral cefixime is recommended as first-line treatment of gonorrhea in the United States. Antimicrobial susceptibility patterns should be monitored. Doxycycline therapy for 7 days (if not pregnant) or single dose azithromycin is also recommended to treat possible concurrent chlamydial infection. The patient's sexual partner(s) should also be evaluated/treated.
Usual Adult Dose for Granuloma Inguinale:
CDC recommendations: 750 mg orally twice a day for at least 3 weeks and until all lesions have completely healed Ciprofloxacin Myungmoon is recommended as an alternate regimen by the CDC. Doxycycline is considered the drug of choice. The patient's sexual partner(s) should also be evaluated/treated.
Usual Adult Dose for Infection Prophylaxis:
(Not approved by FDA) Patients with neutropenia: 500 mg orally every 12 hours; alternatively, 400 mg IV every 12 hours may be given for particularly ill patients The duration of therapy may vary with the duration of the patient's neutropenia.
Usual Adult Dose for Infectious Diarrhea:
Mild/moderate/severe: 500 mg orally every 12 hours for 5 to 7 days IDSA recommendations: E coli species, Aeromonas, Plesiomonas: 500 mg orally twice a day for 3 days
Usual Adult Dose for Diverticulitis:
Complicated intraabdominal infection (used in combination with metronidazole): IV: 400 mg IV every 12 hours Oral: 500 mg orally every 12 hours Duration: 7 to 14 days
Usual Adult Dose for Intraabdominal Infection:
Complicated intraabdominal infection : IV: 400 mg IV every 12 hours Oral: 500 mg orally every 12 hours Duration: 7 to 14 days
Usual Adult Dose for Peritonitis:
Complicated intraabdominal infection (used in combination with metronidazole): IV: 400 mg IV every 12 hours Oral: 500 mg orally every 12 hours Duration: 7 to 14 days
Usual Adult Dose for Joint Infection:
Mild/moderate: IV: 400 mg IV every 12 hours Oral: 500 mg orally every 12 hours Severe/complicated: IV: 400 mg IV every 8 hours Oral: 750 mg orally every 12 hours Duration: at least 4 to 6 weeks
Usual Adult Dose for Osteomyelitis:
Mild/moderate: IV: 400 mg IV every 12 hours Oral: 500 mg orally every 12 hours Severe/complicated: IV: 400 mg IV every 8 hours Oral: 750 mg orally every 12 hours Duration: at least 4 to 6 weeks
Usual Adult Dose for Meningococcal Meningitis Prophylaxis:
CDC recommendations: 500 mg orally once
Usual Adult Dose for Mycobacterium avium-intracellulare -- Treatment:
(Not approved by FDA) 400 mg IV or 750 mg orally every 12 hours, in combination with at least 3 other antimycobacterial drugs (e.g., clarithromycin or azithromycin, ethambutol, rifabutin, amikacin)
Usual Adult Dose for Nosocomial Pneumonia:
Mild/moderate/severe: 400 mg IV every 8 hours for 10 to 14 days Initial empiric treatment with broad-spectrum coverage according to the hospital's and/or ICU's antibiogram is recommended if multidrug-resistant organisms are suspected.
Usual Adult Dose for Plague:
Treatment of plague used as a biological weapon: Treatment, contained-casualty setting: 400 mg IV every 12 hours for 10 days; may switch to oral Ciprofloxacin Myungmoon 500 mg twice a day when clinically indicated The Working Group on Civilian Biodefense has recommended Ciprofloxacin Myungmoon as an alternative to streptomycin and gentamicin if they are contraindicated, unavailable, or inactive in vitro. Treatment, mass-casualty setting: 500 mg orally twice a day for 10 days Postexposure prophylaxis: 500 mg orally twice a day for 7 days The Working Group on Civilian Biodefense has recommended Ciprofloxacin Myungmoon or doxycycline for plague treatment in a mass casualty setting and for postexposure prophylaxis.
Usual Adult Dose for Pneumonia:
Lower respiratory tract infection: Mild/moderate: IV: 400 mg IV every 12 hours Oral: 500 mg orally every 12 hours Severe/complicated: IV: 400 mg IV every 8 hours Oral: 750 mg orally every 12 hours Duration: 7 to 14 days Ciprofloxacin Myungmoon is not considered the drug of choice for the treatment of presumed or confirmed pneumonia secondary to Streptococcus pneumoniae.
Usual Adult Dose for Prostatitis:
Chronic bacterial prostatitis : IV: 400 mg IV every 12 hours Oral: 500 mg orally every 12 hours Duration: 28 days
Usual Adult Dose for Pyelonephritis:
Acute uncomplicated: Cipro(R) XR: 1000 mg orally every 24 hours for 7 to 14 days
Usual Adult Dose for Salmonella Gastroenteritis:
IDSA recommendations: Non-typhi species of Salmonella: 500 mg orally twice a day for 5 to 7 days Up to 14 days (or longer if relapsing) of treatment may be required for immunocompromised patients.
Usual Adult Dose for Shigellosis:
Mild/moderate/severe infectious diarrhea: 500 mg orally every 12 hours for 5 to 7 days IDSA recommendations: 500 mg orally twice a day for 3 days Up to 7 to 10 days of treatment may be required for immunocompromised patients. A single 1 gram dose may be effective for non-dysentery shigellosis.
Usual Adult Dose for Sinusitis:
Mild/moderate: IV: 400 mg IV every 12 hours Oral: 500 mg orally every 12 hours Duration: 10 days
Usual Adult Dose for Skin or Soft Tissue Infection:
Mild/moderate: IV: 400 mg IV every 12 hours Oral: 500 mg orally every 12 hours Severe/complicated: IV: 400 mg IV every 8 hours Oral: 750 mg orally every 12 hours Duration: 7 to 14 days Vibrio vulnificus: 400 mg IV every 12 hours plus ceftazidime 1 to 2 g IV every 8 hours or cefotaxime 2 g IV every 8 hours
Usual Adult Dose for Traveler's Diarrhea:
500 mg orally every 12 hours Therapy should be continued for about 5 to 7 days in severely ill patients. Most cases are self-limited, and prudent withholding of antibiotics in mild cases does not appear to slow recovery in most patients. However, immunocompromised patients may require longer courses of therapy.
Usual Adult Dose for Tuberculosis -- Active:
(Not approved by FDA) 750 mg orally or 400 mg IV every 12 hours May be given in combination with at least 3 other active drugs for treatment of multi-drug resistant TB, or when the patient is intolerant of first-line agents. AFB smear and culture should be monitored monthly. Duration: Treatment for TB should generally continue for 18 to 24 months, or for 12 to 18 months after culture results are negative.
Usual Adult Dose for Tularemia:
Use of tularemia as a biological weapon: Treatment, contained casualty setting: 400 mg IV twice a day for 10 days; may switch to oral Ciprofloxacin Myungmoon 500 mg twice a day when clinically indicated The Working Group on Civilian Biodefense has recommended Ciprofloxacin Myungmoon as an alternative to streptomycin and gentamicin if they are contraindicated, not available, or inactive in vitro. Treatment, mass casualty setting and postexposure prophylaxis: 500 mg orally twice a day for 14 days The Working Group on Civilian Biodefense has recommended Ciprofloxacin Myungmoon or doxycycline for tularemia treatment in a mass casualty setting and for postexposure prophylaxis.
Usual Adult Dose for Salmonella Enteric Fever:
Mild/moderate: 500 mg orally every 12 hours for 10 days
Usual Adult Dose for Typhoid Fever:
Mild/moderate: 500 mg orally every 12 hours for 10 days
Usual Adult Dose for Urinary Tract Infection:
Acute uncomplicated : Immediate-release: 250 mg orally every 12 hours Extended-release: 500 mg orally every 24 hours Duration: 3 days Mild/moderate: IV: 200 mg IV every 12 hours Immediate-release: 250 mg orally every 12 hours Duration: 7 to 14 days Severe/complicated: IV: 400 mg IV every 12 hours (or every 8 hours) Immediate-release: 500 mg orally every 12 hours Cipro(R) XR: 1000 mg orally every 24 hours Duration: 7 to 14 days
Usual Pediatric Dose for Anthrax Prophylaxis:
Prophylaxis postexposure to inhalational Bacillus anthracis: IV: 10 mg/kg IV every 12 hours (maximum dose: 400 mg/dose) Oral: 15 mg/kg orally every 12 hours (maximum dose: 500 mg/dose) Treatment should start as soon as possible following suspected or confirmed exposure. Total duration of therapy (IV and oral combined) is 60 days.
Usual Pediatric Dose for Urinary Tract Infection:
Complicated infection due to E coli: 1 to 18 years: IV: 6 to 10 mg/kg IV every 8 hours Oral: 10 to 20 mg/kg orally every 12 hours (maximum dose: 750 mg/dose) Total duration of therapy (IV and oral combined) is 10 to 21 days. Ciprofloxacin Myungmoon is not a drug of first choice due to a higher rate of adverse reactions in this population.
Usual Pediatric Dose for Pyelonephritis:
Due to E coli: 1 to 18 years: IV: 6 to 10 mg/kg IV every 8 hours (maximum dose: 400 mg/dose) Oral: 10 to 20 mg/kg orally every 12 hours (maximum dose: 750 mg/dose) Total duration of therapy (IV and oral combined) is 10 to 21 days. Ciprofloxacin Myungmoon is not a drug of first choice due to a higher rate of adverse reactions in this population.
Usual Pediatric Dose for Inhalation Bacillus anthracis:
CDC recommendations: Treatment of inhalational anthrax associated with bioterrorism attack: Children: 10 to 15 mg/kg IV every 12 hours (not to exceed 1 g/day) plus 1 or 2 additional antibiotics with activity against the causative organism; these drugs may include rifampin, vancomycin, penicillin, ampicillin, chloramphenicol, imipenem, clindamycin, and clarithromycin Duration: The switch from IV to oral antimicrobial therapy [ciprofloxacin 10 to 15 mg/kg orally every 12 hours (not to exceed 1 g/day)] should occur as soon as is clinically feasible. Therapy should continue for a total of 60 days (IV and oral combined).
Usual Pediatric Dose for Cutaneous Bacillus anthracis:
(Not approved by FDA) CDC recommendations: Treatment of cutaneous anthrax associated with bioterrorism attack: Children: 10 to 15 mg/kg orally every 12 hours (not to exceed 1 g/day) for 60 days IV therapy [ciprofloxacin 10 to 15 mg/kg IV every 12 hours (not to exceed 1 g/day)] with multiple drugs is recommended if there is evidence of systemic involvement, severe edema, or if head or neck lesions are present.
Usual Pediatric Dose for Pneumonia with Cystic Fibrosis:
Study (n=67) 5 years or older: 10 mg/kg IV every 8 hours for 1 week followed by 20 mg/kg orally every 12 hours Total duration of therapy: 10 to 21 days
Usual Pediatric Dose for Plague:
(Not approved by FDA) Use of plague as a biological weapon: Treatment, contained-casualty setting: 15 mg/kg IV twice a day for 10 days (maximum dose: 1 g/day); may switch to oral Ciprofloxacin Myungmoon when clinically indicated The Working Group on Civilian Biodefense has recommended Ciprofloxacin Myungmoon as an alternative to streptomycin and gentamicin if they are contraindicated, unavailable, or inactive in vitro. Treatment, mass casualty setting: 20 mg/kg orally twice a day for 10 days (maximum dose: 1 g/day) Postexposure prophylaxis: 20 mg/kg orally twice a day for 7 days (maximum dose: 1 g/day) The Working Group on Civilian Biodefense has recommended Ciprofloxacin Myungmoon or doxycycline for plague treatment in a mass casualty setting and for postexposure prophylaxis.
Usual Pediatric Dose for Tularemia:
Use of tularemia as a biological weapon: Treatment, contained casualty setting: 15 mg/kg IV twice a day (maximum dose: 1 g/day) for 10 days; may switch to oral Ciprofloxacin Myungmoon when clinically indicated The Working Group on Civilian Biodefense has recommended Ciprofloxacin Myungmoon as an alternative to streptomycin and gentamicin if they are contraindicated, not available, or inactive in vitro. Treatment, mass casualty setting and postexposure prophylaxis: 15 mg/kg orally twice a day (maximum dose: 1 g/day) for 14 days The Working Group on Civilian Biodefense has recommended doxycycline or Ciprofloxacin Myungmoon for tularemia treatment in a mass casualty setting and for postexposure prophylaxis.
Dailymed."Ciprofloxacin; dexamethasone: dailymed provides trustworthy information about marketed drugs in the united states. dailymed is the official provider of fda label information (package inserts).". https://dailymed.nlm.nih.gov/dailym... (accessed August 28, 2018).
Can Ciprofloxacin Myungmoon be stopped immediately or do I have to stop the consumption gradually to ween off?
In some cases, it always advisable to stop the intake of some medicines gradually because of the rebound effect of the medicine.
It's wise to get in touch with your doctor as a professional advice is needed in this case regarding your health, medications and further recommendation to give you a stable health condition.
Who should not take Ciprofloxacin Myungmoon?
You should not use Ciprofloxacin Myungmoon if you are allergic to it, or if:
you are also taking tizanidine; or
you are allergic to other fluoroquinolones.
You may not be able to use Ciprofloxacin Myungmoon if you have a muscle disorder. Tell your doctor if you have a history of myasthenia gravis.
To make sure Ciprofloxacin Myungmoon is safe for you, tell your doctor if you have:
tendon problems, arthritis or other joint problems (especially in children);
a muscle or nerve disorder;
a heart rhythm disorder, especially if you take medication to treat it;
a personal or family history of Long QT syndrome;
coronary artery disease (hardened arteries);
liver disease;
kidney disease;
seizures or epilepsy;
a history of head injury or brain tumor;
diabetes (especially if you take oral diabetes medication); or
low levels of potassium in your blood (hypokalemia).
Ciprofloxacin Myungmoon may cause swelling or tearing of a tendon (the fiber that connects bones to muscles in the body), especially in the Achilles' tendon of the heel. This can happen during treatment or up to several months after you stop using Ciprofloxacin Myungmoon. Tendon problems may be more likely to occur if you are over 60, if you use steroid medication, or if you have had a kidney, heart, or lung transplant.
FDA pregnancy category C. It is not known whether Ciprofloxacin Myungmoon will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medicine.
Ciprofloxacin Myungmoon can pass into breast milk and may harm a nursing baby. You should not breast-feed while using this medicine.
Do not give this medicine to anyone under 18 years old without medical advice.
What other drugs will affect Ciprofloxacin Myungmoon?
Tell your doctor about all medicines you use, and those you start or stop using during your treatment with Ciprofloxacin Myungmoon, especially:
medicine to treat depression or mental illness--amitriptylline, clomipramine, desipramine, iloperidone, imipramine, nortriptyline, thioridazine, ziprasidone, and others; or
This list is not complete. Other drugs may interact with Ciprofloxacin Myungmoon, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed in this medication guide.
How should I take Ciprofloxacin Myungmoon?
You should not use this medicine if you are also taking tizanidine.
You may not be able to use Ciprofloxacin Myungmoon if you have a muscle disorder. Tell your doctor if you have a history of myasthenia gravis.
Ciprofloxacin Myungmoon may cause swelling or tearing of a tendon (the fiber that connects bones to muscles in the body), especially in the Achilles' tendon of the heel. This effect may be more likely to occur if you are over 60, if you use steroid medication, or if you have had a kidney, heart, or lung transplant.
Call your doctor at once if you have sudden pain, swelling, bruising, tenderness, stiffness, or movement problems in any of your joints. Rest the joint until you receive medical care or instructions.
Can Ciprofloxacin Myungmoon be taken or consumed while pregnant?
Please visit your doctor for a recommendation as such case requires special attention.
Can Ciprofloxacin Myungmoon be taken for nursing mothers or during breastfeeding?
Kindly explain your state and condition to your doctor and seek medical advice from an expert.
Reviews
Following the study conducted by gmedication.com on Ciprofloxacin Myungmoon, the result is highlighted below. However, it must be clearly stated that the survey and result is based solely on the perception and impression of visitors and users of the website as well as consumers of Ciprofloxacin Myungmoon. We, therefore, urge readers not to base their medical judgment strictly on the result of this study but on test/diagnosis duly conducted by a certified medical practitioners or physician.
Patient reports
Patient reported useful
No survey data has been collected yet
Patient reported side effects
No survey data has been collected yet
Patient reported price estimates
No survey data has been collected yet
Patient reported frequency of use
No survey data has been collected yet
Patient reported doses
No survey data has been collected yet
Patient reported time for results
No survey data has been collected yet
Patient reported administration
No survey data has been collected yet
Patient reported age
No survey data has been collected yet
Patient reviews
There are no reviews yet. Be the first to write one!